To reiterate, as Dr. Kochhar has said, the stockpile is monitored on an ongoing basis. As well, we certainly profit from our ongoing collaboration with the provinces and territories. As part of our governance structure in response to a public health event, a biological event, we have a logistics advisory committee whereby we are repeatedly talking to them about the variety of product holdings, as well as distribution models. I think that was previously referenced. Certainly we will work with them in terms of the allocation model.
We've also taken advantage of reaching out with experts in the field to inform us on forward-looking requirements in terms of what ICU biomedical equipment would be most relevant in the case of a respiratory illness of this nature, so we are continuously looking at the whole thing.